-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $340 Price Target

Benzinga·12/08/2025 12:21:16
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $340 price target.